|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Sarcoma
Whole-Genome and Transcriptome Sequencing Identified
NOTCH2
and
HES1
as Potential Markers of Response to
Imatinib
in Desmoid Tumor (Aggressive Fibromatosis): A Phase II Trial Study
Joonha Kwon, Jun Hyeong Lee, Young Han Lee, Jeeyun Lee, Jin-Hee Ahn, Se Hyun Kim, Seung Hyun Kim, Tae Il Kim, Kum-Hee Yun, Young Suk Park, Jeong Eun Kim, Kyu Sang Lee, Jung Kyoon Choi, Hyo Song Kim
Cancer Res Treat.
2022;54(4):1240-1255. Published online January 17, 2022 DOI:
https://doi.org/10.4143/crt.2021.1194
Web of Science 4
Crossref 4
Gastrointestinal cancer
Adjuvant
Imatinib
Treatment for 5 Years versus 3 Years in Patients with Ruptured Localized Gastrointestinal Stromal Tumor: A Retrospective Analysis
Sora Kang, Min-Hee Ryu, Yeong Hak Bang, Hyung-Don Kim, Hyung Eun Lee, Yoon-Koo Kang
Cancer Res Treat.
2022;54(4):1167-1174. Published online December 6, 2021 DOI:
https://doi.org/10.4143/crt.2021.1040
Web of Science 4
Crossref 7
Identification of a Novel
CSNK2A1
-
PDGFRB
Fusion Gene in a Patient with Myeloid Neoplasm with Eosinophilia
Xiaoyu Xu, Qiongyu Lu, Zheng Wang, Ping Cai, Zhao Zeng, Ling Zhang, Man Wang, Liang Ma, Changgeng Ruan, Suning Chen
Cancer Res Treat.
2021;53(3):889-892. Published online December 24, 2020 DOI:
https://doi.org/10.4143/crt.2020.1272
Crossref 6
Factors Influencing
Imatinib
-Induced Hepatotoxicity
Ji Min Han, Jeong Yee, Yoon Sook Cho, Hye Sun Gwak
Cancer Res Treat.
2020;52(1):181-188. Published online June 26, 2019 DOI:
https://doi.org/10.4143/crt.2019.131
Web of Science 14
Crossref 12
Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of
Imatinib
and Sunitinib: A Multicenter Study Based on the Management Access Program
Myoung Kyun Son, Min-Hee Ryu, Joon Oh Park, Seock-Ah Im, Tae-Yong Kim, Su Jin Lee, Baek-Yeol Ryoo, Sook Ryun Park, Yoon-Koo Kang
Cancer Res Treat.
2017;49(2):350-357. Published online July 19, 2016 DOI:
https://doi.org/10.4143/crt.2016.067
Web of Science 22
Crossref 17
Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor
Dong-Hoe Koo, Min-Hee Ryu, Kyoung-Mee Kim, Han-Kwang Yang, Akira Sawaki, Seiichi Hirota, Jie Zheng, Bo Zhang, Chin-Yuan Tzen, Chun-Nan Yeh, Toshirou Nishida, Lin Shen, Li-Tzong Chen, Yoon-Koo Kang
Cancer Res Treat.
2016;48(4):1155-1166. Published online June 24, 2016 DOI:
https://doi.org/10.4143/crt.2016.187
Web of Science 136
Crossref 122
A Multi-centric Bioequivalence Trial in Ph+ Chronic Myeloid Leukemia Patients to Assess Bioequivalence and Safety Evaluation of Generic
Imatinib
Mesylate 400 mg Tablets
Rachna Arora, Manju Sharma, Tausif Monif, Sunil Iyer
Cancer Res Treat.
2016;48(3):1120-1129. Published online February 12, 2016 DOI:
https://doi.org/10.4143/crt.2015.436
Web of Science 8
Crossref 8
Efficacy of
Imatinib
in Patients with Platelet-Derived Growth Factor Receptor Alpha–Mutated Gastrointestinal Stromal Tumors
Changhoon Yoo, Min-Hee Ryu, Jungmin Jo, Inkeun Park, Baek-Yeol Ryoo, Yoon-Koo Kang
Cancer Res Treat.
2016;48(2):546-552. Published online June 22, 2015 DOI:
https://doi.org/10.4143/crt.2015.015
Web of Science 36
Crossref 31
Severe
Imatinib
-Associated Skin Rash in Gastrointestinal Stromal Tumor Patients: Management and Clinical Implications
Sook Ryun Park, Min-Hee Ryu, Baek-Yeol Ryoo, Mo Youl Beck, In Soon Lee, Mi Jung Choi, Mi Woo Lee, Yoon-Koo Kang
Cancer Res Treat.
2016;48(1):162-170. Published online September 1, 2015 DOI:
https://doi.org/10.4143/crt.2015.017
Web of Science 12
Crossref 12
Clinical Practice Guideline for Accurate Diagnosis and Effective Treatment of Gastrointestinal Stromal Tumor in Korea
Yoon-Koo Kang, Hye Jin Kang, Kyoung-Mee Kim, Taesung Sohn, Dongil Choi, Min-Hee Ryu, Woo Ho Kim, Han-Kwang Yang
Cancer Res Treat.
2012;44(2):85-96. Published online June 30, 2012 DOI:
https://doi.org/10.4143/crt.2012.44.2.85
Crossref 32
Effect on Cell Cycle Progression by N-Myc Knockdown in SK-N-BE(2) Neuroblastoma Cell Line and Cytotoxicity with STI-571 Compound
Un-Young Yu, Je-Eun Cha, Sun-Young Ju, Kyung-Ah Cho, Eun-Sun Yoo, Kyung-Ha Ryu, So-Youn Woo
Cancer Res Treat.
2008;40(1):27-32. Published online March 31, 2008 DOI:
https://doi.org/10.4143/crt.2008.40.1.27
Crossref 6
Neoadjuvant
Imatinib
in Locally Advanced Gastrointestinal Stromal Tumors of the Stomach: Report of Three Cases
Ji Seon Oh, Jae-Lyun Lee, Mi-Jung Kim, Min-Hee Ryu, Heung Moon Chang, Tae Won Kim, Se Jin Jang, Jeong Hwan Yook, Sung Tae Oh, Byung Sik Kim, Yoon-Koo Kang
Cancer Res Treat.
2006;38(3):178-183. Published online June 30, 2006 DOI:
https://doi.org/10.4143/crt.2006.38.3.178
Crossref 7
1
Journal Impact Factor 4.6